Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$70,000.00
Epigenomic studies of twins discordant for Crohn's disease
EF 2008-09
Résumé
Crohn's is a chronic, idiopathic inflammatory bowel disease with origins that cannot be explained by traditional genetics. Identical or monozygotic (MZ) twins are discordantly affected with Crohn's; discordance is usually thought to be due to environmental causes, but no Crohn's-specific environmental factors have yet been identified. Epigenetics, the regulation of genomic activity via DNA methylation and histone modification, may offer insight on the causes of this disease and many others. It is possible for genetically identical organisms to show different physical traits if their epigenetic profiles differ; this can be due to stochastic, environmental, developmental, or other factors. I plan to examine the epigenetic (specifically, DNA methylation) profiles of twins discordant for Crohn's disease to determine if methylation differences exist and if these differences can account for the presence of the disease in only one co-twin. DNA will be extracted from gut biopsy material of 40 MZ and dizygotic (DZ) twins and subjected to microarray based DNA methylation profiling. DNA from non-gut cells, such as peripheral blood leukocytes and buccal epithelium, will also be tested in order to differentiate the causal from non-causal epigenetic changes in Crohn's. Preparation for array hybridization includes digestion with methylation-sensitive restriction enzymes, ligation to DNA adaptors, PCR amplification, and labelling with fluorescent dyes. Bisulfite modification mapping will be used to verify the loci that show the greatest and most significant between-twin differences on the arrays. Sodium bisulfite converts unmethylated cytosines into uracils, which become thymines during PCR, while the methylated cytosines are protected and do not change. Identification of epigenetic misregulation predisposing to Crohn's disease is a valuable step towards creation of new therapies and diagnostics, and would shed light on the role of epigenetic factors in complex diseases.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
184379
Name
Ptak Carolyn
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Epigenomic studies of twins discordant for Crohn's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Biopsy; Bisulfite Modification; Crohn'S; Diagnostics; Discordance; Dna Methylation; Epigenomics; Etiopathogenesis; Microarray; Pyrosequencing
Abstract
Crohn's is a chronic, idiopathic inflammatory bowel disease with origins that cannot be explained by traditional genetics. Identical or monozygotic (MZ) twins are discordantly affected with Crohn's; discordance is usually thought to be due to environmental causes, but no Crohn's-specific environmental factors have yet been identified. Epigenetics, the regulation of genomic activity via DNA methylation and histone modification, may offer insight on the causes of this disease and many others. It is possible for genetically identical organisms to show different physical traits if their epigenetic profiles differ; this can be due to stochastic, environmental, developmental, or other factors. I plan to examine the epigenetic (specifically, DNA methylation) profiles of twins discordant for Crohn's disease to determine if methylation differences exist and if these differences can account for the presence of the disease in only one co-twin. DNA will be extracted from gut biopsy material of 40 MZ and dizygotic (DZ) twins and subjected to microarray based DNA methylation profiling. DNA from non-gut cells, such as peripheral blood leukocytes and buccal epithelium, will also be tested in order to differentiate the causal from non-causal epigenetic changes in Crohn's. Preparation for array hybridization includes digestion with methylation-sensitive restriction enzymes, ligation to DNA adaptors, PCR amplification, and labelling with fluorescent dyes. Bisulfite modification mapping will be used to verify the loci that show the greatest and most significant between-twin differences on the arrays. Sodium bisulfite converts unmethylated cytosines into uracils, which become thymines during PCR, while the methylated cytosines are protected and do not change. Identification of epigenetic misregulation predisposing to Crohn's disease is a valuable step towards creation of new therapies and diagnostics, and would shed light on the role of epigenetic factors in complex diseases.
Competitiondate
200810
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Ptak, Carolyn
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~